GuidelineNeuro-oncology2020
EANO guideline on the diagnosis and treatment of vestibular schwannoma.
Guideline in Neuro-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 219 papers, 19 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
219 citing papers in PubMed, 19 syntheses or guidelines pooled it, 416 citations in OpenAlex.
- Socioeconomic disparities in vestibular schwannoma diagnosis and management: A systematic review.Neurosurgical review · 2026Pooled it
- Machine learning for functional outcome prediction after vestibular schwannoma surgery: a systematic review and diagnostic test accuracy meta-analysis.Journal of neuro-oncology · 2026Pooled it
- Beyond the naked eye: a systematic review on the current state of radiomics approaches to the vestibular schwannoma.Journal of neuro-oncology · 2026Pooled it
- Salvage surgery following primary treatment in recurrent vestibular schwannoma: surgical outcomes and progression-free survival- a meta-analysis.Journal of neuro-oncology · 2026Pooled it
- The fundal cerebrospinal fluid cap in vestibular schwannoma surgery: a predictor of outcome after the retrosigmoid approach.Neurosurgical review · 2026Pooled it
- Intraoperative auditory monitoring in vestibular schwannoma surgery: Diagnostic accuracy and interventional effectiveness - a systematic review.Neurosurgical review · 2026Pooled it
- Health-related quality of life in patients with vestibular schwannoma managed with observation, stereotactic radiosurgery or microsurgery: a systematic review and single-arm meta-analysis.Journal of neurology · 2026Pooled it
- A systematic evaluation of clinical practice guidelines for the treatment and management of vestibular schwannoma.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025Pooled it
- Characterization of facial nerve outcomes following radiosurgery for vestibular schwannoma: a meta-analysis.Acta neurochirurgica · 2025Pooled it
- Research trends of facial nerve injury after cerebellopontine angle tumor: CiteSpace-based bibliometric analysis.Frontiers in neurology · 2025Pooled it
- Pooled it
- Hearing preservation and quality of life in small to medium sized vestibular schwannomas after a wait and scan approach or stereotactic radiosurgery: a systematic review and meta-analysis.Acta neurochirurgica · 2024Pooled it
- Prevalence and patterns of cerebral venous sinus thrombosis following vestibular schwannoma surgery: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024Pooled it
- Hearing preservation surgery for vestibular schwannoma: a systematic review and meta-analysis.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2024Pooled it
- Cost considerations for vestibular schwannoma screening and imaging: a systematic review.Neurosurgical review · 2024Pooled it
- Application of diffusion tensor imaging of the facial nerve in preoperative planning for large vestibular schwannoma: a systematic review.Neurosurgical review · 2023Pooled it
- Single-fraction stereotactic radiosurgery versus microsurgical resection for the treatment of vestibular schwannoma: a systematic review and meta-analysis.Systematic reviews · 2022Pooled it
- Evaluating growth trends of residual sporadic vestibular schwannomas: a systematic review and meta-analysis.Journal of neuro-oncology · 2022Pooled it
- Diagnostic accuracy of intraoperative brainstem auditory evoked potential for predicting hearing loss after vestibular schwannoma surgery.Frontiers in neurology · 2022Pooled it
- Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.Neuro-oncology · 2023Trial
159 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 12 institutions in 8 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The level of evidence to provide treatment recommendations for vestibular schwannoma is low compared with other intracranial neoplasms. Therefore, the vestibular schwannoma task force of the European Association of Neuro-Oncology assessed the data available in the literature and composed a set of recommendations for health care professionals. The radiological diagnosis of vestibular schwannoma is made by magnetic resonance imaging. Histological verification of the diagnosis is not always required. Current treatment options include observation, surgical resection, fractionated radiotherapy, and radiosurgery. The choice of treatment depends on clinical presentation, tumor size, and expertise of the treating center. In small tumors, observation has to be weighed against radiosurgery, in large tumors surgical decompression is mandatory, potentially followed by fractionated radiotherapy or radiosurgery. Except for bevacizumab in neurofibromatosis type 2, there is no role for pharmacotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.